HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
Benoy V, Van Helleputte L, Prior R, d'Ydewalle C, Haeck W, Geens N, Scheveneels W, Schevenels B, Cader MZ, Talbot K, Kozikowski AP, Vanden Berghe P, Van Damme P, Robberecht W, Van Den Bosch L.
Benoy V, et al. Among authors: cader mz.
Brain. 2018 Mar 1;141(3):673-687. doi: 10.1093/brain/awx375.
Brain. 2018.
PMID: 29415205
Free PMC article.